Detailled Information

Name of the Instrument/Tool Disease Extent Index (DEI)
First Description

de Groot K, Gross WL, Herlyn K, Reinhold-Keller E. Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol. 2001 Jan;55(1):31-8. PMID: 11200865.

Year 2001
Domains
Concept of constructs Disease activity
Population/Disease Disease specific
Originally developed for ANCA-associated vasculitis (AAV)
Other rheumatic diseases
where can be applied (only if validated)
---
Additional population with no rheumatic diseases No
Language: Originally published in English
Available in Language German
REFERENCE IDENTIFICATION
Author/s de Groot, K. and Gross, W. L. and Herlyn, K. and Reinhold-Keller, E.
Title Intra- and inter-rater reliability of endonasal activity estimation in granulomatosis with polyangiitis (Wegener's)
Journal Clin Exp Rheumatol
Year 2001
Vol 30
Num 70
Pages 22-8
Country Germany
Language English
Other references of interest
Link https://pubmed.ncbi.nlm.nih.gov/17519271/
Brief Description

Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. 

Instrument/Tool Translations References
No other References.
DEVELOPER CONTACT INFORMATION
Correspondence to K. de Groot
E-Mail kirsten@de-groot.de
Address Department of Otorhinolaryngology, Head and Neck Surgery, University of Kiel, Kiel, Germany.
Website ---
Available ---
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Score
Brief Description

The DEI is valid, reliable, easy, quick to perform and highly reproducible to assess disease extent (staging) and activity (grading) in patients with ANCA-associated vasculitides.

Number of Items 11
Range 0-21
Responses options/scale Yes
Scale
Developed for Clinical practice
PRACTICAL APPLICATION
Method of administration Physician
Recommendations to score

Some items are scored higher (weighted score)

Score Interpretation Higher scores indicate higher disease extent.
Cut-off points ---
Cut-off points applied to ---
Smallest detectable change if described -
Smallest detectable change applied to ---
Completion time by the patient - minutes
Scoring time by the assessor 1 minutes
Training to score Not necessary
Strengths Useful in clinical practice & research, Easy to use
Limitations ---
OTHER COMMENTS
Other Comments ---